1. MARKETS
  2. SECTOR : PHARMACEUTICALS & BIOTECHNOLOGY
  3. INDUSTRY : PHARMACEUTICALS
  4. ALIVUS LIFE SCIENCES LTD.
Alivus Life Sciences Ltd.
NSE: ALIVUS | BSE: 543322
Iran War Impact
Ask MarketMind AI
1063.10 2.30 (0.22%)
55,857
NSE+BSE Volume

NSE 21 May, 2026 2:17 PM (IST)

Watchlist

Portfolio

Alert

Alivus Life Sciences - ALIVUS - stock price prediction, stock forecast, target price, analyst ratings from 4 analysts

Alivus Life Sciences has a share price target of Rs 1229, revenue growth forecast of 9.8%, and profit growth estimate of 22.0% for FY27, based on top 4 analyst calls.